Evidence map›Paper›PMID 29110000›Full record

ArticleNanoscale2017

Carbon dots: promising biomaterials for bone-specific imaging and drug delivery.

Zhili Peng, Esmail H Miyanji, Yiqun Zhou, Joel Pardo, Sajini D Hettiarachchi, Shanghao Li, Patricia L Blackwelder, Isaac Skromne, Roger M Leblanc

Abstract read
In one paragraph

Article in Nanoscale, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Article
  3. Carbon dots-based drug delivery for bone regeneration.Frontiers in bioengineering and biotechnology · 2025
    Review
  4. Synthesis andHeliyon · 2024
    Article
  5. Quantum dots for bone tissue engineering.Materials today. Bio · 2024
    Review
  6. Colloidal Chiral Carbon Dots: An Emerging System for Chiroptical Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Sensitive, Selective and Reliable Detection of FeMolecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhili PengCollege of Pharmacy and Chemistry, Dali University, Dali, Yunnan 671000, P. R. China.
Esmail H Miyanji
Yiqun Zhou
Joel Pardo
Sajini D Hettiarachchi
Shanghao Li
Patricia L Blackwelder
Isaac Skromne
Roger M Leblanc

Funding

Testing the therapeutic potential of carbon nanodots in bone mineralization diseasesR21AR072226 · NIAMS · UNIVERSITY OF RICHMOND · PI SKROMNE, ISAAC · 2017 to 2018
$316k
NIAMS NIH HHS R21 AR072226
6 · The paper itself

Abstract

Bone-related diseases and dysfunctions are heavy burdens on our increasingly aged society. One important strategy to relieve this problem is through early detection and treatment of bone-related diseases. Towards this goal, there has been constant interest in developing novel bone-specific materials for imaging and drug delivery. Currently, however, materials that have high affinity and specificity towards bone are very limited. Carbon dots (C-dots) synthesized from carbon nanopowder bind to calcified bones in vivo with high affinity and specificity. In this study we show that bone binding is highly unique to a specific type of C-dot, and that this binding is non-toxic. Significantly, C-dots derived from other raw materials did not show any bone binding properties. These differences are attributed to the differences in surface chemistry of C-dot preparations, highlighting the heterogeneous nature of C-dots. Importantly, bone-binding by carbon nanopowder derived C-dots is not significantly altered by chemical functionalization of their surface. These unique properties indicate the potential applications of carbon nanopowder-derived C-dots as highly bone-specific bioimaging agents and drug carriers.

Indexed as

Quantum DotsAnimalsBiocompatible MaterialsBone and BonesCarbonDrug CarriersEmbryo, NonmammalianZebrafishBiocompatible MaterialsCarbonDrug Carriers

Identifiers

PMID29110000
PMCPMC5691292

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.